$1.17 Billion is the total value of Bellevue Group AG's 138 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 30.6% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ANTM | Buy | ANTHEM INC | $50,826,000 | +27.6% | 213,527 | +17.8% | 4.33% | +9.8% |
ALGN | Sell | ALIGN TECHNOLOGY INC | $44,840,000 | +10.6% | 131,058 | -18.8% | 3.82% | -4.8% |
CELG | Buy | CELGENE CORP | $42,315,000 | +9.2% | 532,800 | +22.7% | 3.61% | -6.0% |
ISRG | Buy | INTUITIVE SURGICAL INC | $41,981,000 | +23.1% | 87,739 | +6.2% | 3.58% | +6.0% |
ILMN | Buy | ILLUMINA INC | $39,372,000 | +30.8% | 140,971 | +10.8% | 3.36% | +12.6% |
ABT | Buy | ABBOTT LABS | $34,694,000 | +2.5% | 568,850 | +0.7% | 2.96% | -11.8% |
MDT | Buy | MEDTRONIC PLC | $34,405,000 | +20.1% | 401,881 | +12.6% | 2.93% | +3.4% |
TDOC | Buy | TELADOC INC | $33,095,000 | +59.2% | 570,110 | +10.6% | 2.82% | +37.0% |
EW | Buy | EDWARDS LIFESCIENCES CORP | $29,938,000 | +8.8% | 205,660 | +4.3% | 2.55% | -6.3% |
JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $28,418,000 | +24.0% | 164,933 | +8.7% | 2.42% | +6.7% |
BSX | Buy | BOSTON SCIENTIFIC CORP | $26,833,000 | +41.1% | 820,596 | +17.9% | 2.29% | +21.4% |
HUM | Buy | HUMANA INC | $25,849,000 | +14.9% | 86,850 | +3.8% | 2.20% | -1.1% |
DXCM | Sell | DEXCOM INC | $25,730,000 | -2.6% | 270,897 | -24.0% | 2.19% | -16.2% |
UNH | Sell | UNITEDHEALTH GROUP INC | $23,731,000 | -22.2% | 96,729 | -32.2% | 2.02% | -33.1% |
DHR | Buy | DANAHER CORP DEL | $21,558,000 | +9.0% | 218,465 | +8.2% | 1.84% | -6.2% |
CI | Buy | CIGNA CORPORATION | $21,453,000 | +121.9% | 126,234 | +119.0% | 1.83% | +90.9% |
ABC | Buy | AMERISOURCEBERGEN CORP | $20,367,000 | +9.8% | 238,853 | +11.0% | 1.74% | -5.5% |
ALXN | Buy | ALEXION PHARMACEUTICALS INC | $20,327,000 | +38.8% | 163,730 | +24.6% | 1.73% | +19.4% |
CNC | Buy | CENTENE CORP DEL | $20,114,000 | +56.8% | 163,247 | +36.0% | 1.72% | +34.9% |
SYK | Buy | STRYKER CORP | $20,056,000 | +10.0% | 118,770 | +4.8% | 1.71% | -5.3% |
SUPN | Buy | SUPERNUS PHARMACEUTICALS INC | $19,547,000 | +47.8% | 326,600 | +13.1% | 1.67% | +27.2% |
BDX | Buy | BECTON DICKINSON & CO | $19,456,000 | +79.6% | 81,215 | +62.4% | 1.66% | +54.6% |
MYL | Buy | MYLAN N V | $18,155,000 | +88.5% | 502,350 | +114.7% | 1.55% | +62.3% |
HRC | Buy | HILL ROM HLDGS INC | $15,694,000 | +14.2% | 179,689 | +13.8% | 1.34% | -1.7% |
BAX | Sell | BAXTER INTL INC | $15,506,000 | +10.4% | 210,000 | -2.8% | 1.32% | -5.0% |
WMGI | Buy | WRIGHT MED GROUP NV | $14,805,000 | +37.7% | 570,301 | +5.3% | 1.26% | +18.5% |
BMY | Buy | BRISTOL MYERS SQUIBB CO | $14,435,000 | +470.6% | 260,849 | +552.1% | 1.23% | +390.4% |
HOLX | Sell | HOLOGIC INC | $14,385,000 | -20.4% | 361,894 | -25.2% | 1.23% | -31.5% |
KTWO | Sell | K2M GROUP HLDGS INC | $13,791,000 | +9.0% | 612,941 | -8.2% | 1.18% | -6.2% |
WBA | Sell | WALGREENS BOOTS ALLIANCE INC | $13,564,000 | -21.4% | 226,018 | -14.2% | 1.16% | -32.4% |
LH | Buy | LABORATORY CORP AMER HLDGS | $13,508,000 | +39.8% | 75,240 | +26.0% | 1.15% | +20.4% |
IONS | Buy | IONIS PHARMACEUTICALS INC | $13,442,000 | -2.3% | 322,586 | +3.3% | 1.15% | -15.9% |
FIT | Sell | FITBIT INCcl a | $13,438,000 | +14.8% | 2,057,900 | -10.3% | 1.15% | -1.2% |
MGNX | Buy | MACROGENICS INC | $12,326,000 | -13.0% | 596,913 | +6.0% | 1.05% | -25.1% |
ESPR | Buy | ESPERION THERAPEUTICS INC NEW | $12,287,000 | -1.6% | 313,520 | +81.5% | 1.05% | -15.4% |
PRAH | New | PRA HEALTH SCIENCES INC | $12,081,000 | – | 129,400 | +100.0% | 1.03% | – |
ALDR | Buy | ALDER BIOPHARMACEUTICALS INC | $11,992,000 | +34.8% | 758,964 | +8.4% | 1.02% | +16.0% |
BIIB | Sell | BIOGEN INC | $11,419,000 | -9.7% | 39,345 | -14.8% | 0.97% | -22.3% |
GILD | Sell | GILEAD SCIENCES INC | $11,356,000 | -9.9% | 160,300 | -4.1% | 0.97% | -22.5% |
ABMD | Sell | ABIOMED INC | $11,077,000 | +39.7% | 27,081 | -0.6% | 0.94% | +20.1% |
SHPG | Buy | SHIRE PLCsponsored adr | $11,021,000 | +26.2% | 65,292 | +11.7% | 0.94% | +8.7% |
LIVN | Buy | LIVANOVA PLC | $10,973,000 | +30.9% | 109,924 | +16.0% | 0.94% | +12.5% |
ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $10,194,000 | +293.6% | 103,500 | +375.9% | 0.87% | +238.1% |
INSM | Buy | INSMED INC | $10,029,000 | +33.1% | 424,051 | +26.8% | 0.86% | +14.6% |
HCM | Buy | HUTCHISON CHINA MEDITECH LTDsponsored adr | $10,023,000 | +12.1% | 332,536 | +10.0% | 0.85% | -3.6% |
AKCA | Buy | AKCEA THERAPEUTICS INC | $8,993,000 | +619.4% | 379,301 | +677.3% | 0.77% | +518.5% |
AMGN | Sell | AMGEN INC | $8,842,000 | -24.5% | 47,900 | -30.3% | 0.75% | -35.0% |
RMD | Sell | RESMED INC | $8,514,000 | -19.2% | 82,200 | -23.2% | 0.73% | -30.5% |
ZBH | Sell | ZIMMER BIOMET HLDGS INC | $7,957,000 | -12.1% | 71,401 | -14.0% | 0.68% | -24.4% |
GNMK | GENMARK DIAGNOSTICS INC | $7,570,000 | +17.3% | 1,186,502 | 0.0% | 0.64% | +0.8% | |
VRTX | Sell | VERTEX PHARMACEUTICALS INC | $7,188,000 | -54.4% | 42,294 | -56.3% | 0.61% | -60.8% |
TMO | Buy | THERMO FISHER SCIENTIFIC INC | $6,034,000 | +22.5% | 29,131 | +22.2% | 0.51% | +5.3% |
REGN | Sell | REGENERON PHARMACEUTICALS | $5,955,000 | -36.8% | 17,260 | -37.0% | 0.51% | -45.6% |
WCG | New | WELLCARE HEALTH PLANS INC | $5,430,000 | – | 22,050 | +100.0% | 0.46% | – |
MOH | Buy | MOLINA HEALTHCARE INC | $5,116,000 | +44.9% | 52,240 | +20.1% | 0.44% | +24.6% |
BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $4,665,000 | +29.8% | 49,519 | +11.7% | 0.40% | +11.8% |
COO | Sell | COOPER COS INC | $4,544,000 | -10.9% | 19,300 | -13.5% | 0.39% | -23.4% |
TRHC | Buy | TABULA RASA HEALTHCARE INC | $4,296,000 | +90.9% | 67,306 | +16.0% | 0.37% | +64.1% |
NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $4,278,000 | -3.8% | 43,550 | -18.8% | 0.36% | -17.2% |
TFX | TELEFLEX INC | $3,755,000 | +5.2% | 14,000 | 0.0% | 0.32% | -9.6% | |
IART | Sell | INTEGRA LIFESCIENCES HLDGS C | $3,746,000 | -64.6% | 58,161 | -69.5% | 0.32% | -69.5% |
GMED | Buy | GLOBUS MED INCcl a | $3,736,000 | +53.5% | 74,045 | +51.6% | 0.32% | +32.4% |
HSIC | Buy | SCHEIN HENRY INC | $3,731,000 | +29.1% | 51,368 | +19.5% | 0.32% | +11.2% |
IRTC | Buy | IRHYTHM TECHNOLOGIES INC | $3,726,000 | +77.2% | 45,921 | +37.5% | 0.32% | +52.9% |
INCY | Sell | INCYTE CORP | $3,675,000 | -80.9% | 54,850 | -76.2% | 0.31% | -83.6% |
CERN | Sell | CERNER CORP | $3,462,000 | -6.7% | 57,900 | -9.5% | 0.30% | -19.8% |
ESRX | Sell | EXPRESS SCRIPTS HLDG CO | $3,436,000 | +0.5% | 44,500 | -10.1% | 0.29% | -13.6% |
OMCL | Buy | OMNICELL INC | $3,354,000 | +286.4% | 63,945 | +219.7% | 0.29% | +232.6% |
XENT | Buy | INTERSECT ENT INC | $3,297,000 | +118.3% | 88,028 | +129.1% | 0.28% | +87.3% |
XRAY | Buy | DENTSPLY SIRONA INC | $3,287,000 | +19.9% | 75,093 | +37.8% | 0.28% | +2.9% |
SGEN | Buy | SEATTLE GENETICS INC | $3,286,000 | +28.5% | 49,500 | +1.3% | 0.28% | +10.7% |
HZNP | New | HORIZON PHARMA PLC | $3,173,000 | – | 191,578 | +100.0% | 0.27% | – |
HMSY | Buy | HMS HLDGS CORP | $3,158,000 | +250.5% | 146,069 | +173.0% | 0.27% | +202.2% |
VRX | Buy | VALEANT PHARMACEUTICALS INTL | $3,021,000 | +89.8% | 130,000 | +30.0% | 0.26% | +63.3% |
RARE | Sell | ULTRAGENYX PHARMACEUTICAL INC | $3,009,000 | +46.4% | 39,150 | -2.9% | 0.26% | +26.0% |
QGEN | New | QIAGEN NV | $2,778,000 | – | 76,838 | +100.0% | 0.24% | – |
CHRS | Buy | COHERUS BIOSCIENCES INC | $2,770,000 | +67.1% | 197,835 | +31.9% | 0.24% | +43.9% |
QTNT | Buy | QUOTIENT LTD | $2,568,000 | +395.8% | 319,814 | +190.7% | 0.22% | +329.4% |
TNDM | New | TANDEM DIABETES CARE INC | $2,510,000 | – | 114,006 | +100.0% | 0.21% | – |
EGRX | EAGLE PHARMACEUTICALS INC | $2,497,000 | +43.6% | 33,000 | 0.0% | 0.21% | +23.8% | |
LGND | Sell | LIGAND PHARMACEUTICALS INC | $2,501,000 | -9.1% | 12,070 | -27.5% | 0.21% | -21.7% |
AGIO | Sell | AGIOS PHARMACEUTICALS INC | $2,427,000 | -26.4% | 28,811 | -28.5% | 0.21% | -36.7% |
JNJ | JOHNSON & JOHNSON | $2,427,000 | -5.3% | 20,000 | 0.0% | 0.21% | -18.5% | |
QTRX | Buy | QUANTERIX CORP | $2,376,000 | +66.4% | 165,480 | +97.5% | 0.20% | +44.0% |
TEVA | TEVA PHARMACEUTICAL INDS LTDsponsored adr | $2,189,000 | +42.3% | 90,000 | 0.0% | 0.19% | +23.0% | |
ICPT | Sell | INTERCEPT PHARMACEUTICALS IN | $2,068,000 | +5.4% | 24,648 | -22.7% | 0.18% | -9.3% |
NVRO | Buy | NEVRO CORP | $2,060,000 | +122.2% | 25,798 | +141.1% | 0.18% | +91.3% |
BLUE | Sell | BLUEBIRD BIO INC | $2,025,000 | -10.8% | 12,900 | -3.0% | 0.17% | -23.1% |
HCA | Sell | HCA HEALTHCARE INC | $1,949,000 | -5.7% | 19,000 | -10.8% | 0.17% | -19.0% |
PEN | Sell | PENUMBRA INC | $1,938,000 | -0.3% | 14,027 | -16.5% | 0.16% | -14.1% |
SAGE | Sell | SAGE THERAPEUTICS INC | $1,894,000 | -5.5% | 12,100 | -2.8% | 0.16% | -19.1% |
BGNE | Sell | BEIGENE LTDsponsored adr | $1,768,000 | -74.1% | 11,500 | -71.7% | 0.15% | -77.7% |
INSP | New | INSPIRE MED SYS INC | $1,710,000 | – | 47,953 | +100.0% | 0.15% | – |
RGNX | New | REGENXBIO INC | $1,708,000 | – | 23,800 | +100.0% | 0.15% | – |
NKTR | Sell | NEKTAR THERAPEUTICS | $1,685,000 | -55.3% | 34,500 | -2.8% | 0.14% | -61.5% |
ANGO | Sell | ANGIODYNAMICS INC | $1,684,000 | -4.0% | 75,700 | -25.6% | 0.14% | -17.2% |
AGN | Sell | ALLERGAN PLC | $1,667,000 | -23.8% | 10,000 | -23.1% | 0.14% | -34.6% |
MCK | Sell | MCKESSON CORP | $1,581,000 | -18.7% | 11,850 | -14.1% | 0.14% | -30.1% |
PTLA | Sell | PORTOLA PHARMACEUTICALS INC | $1,567,000 | +12.3% | 41,500 | -2.8% | 0.13% | -2.9% |
PODD | INSULET CORP | $1,543,000 | -1.1% | 18,000 | 0.0% | 0.13% | -14.8% | |
IDXX | New | IDEXX LABS INC | $1,526,000 | – | 7,000 | +100.0% | 0.13% | – |
MASI | Sell | MASIMO CORP | $1,445,000 | -3.3% | 14,800 | -12.9% | 0.12% | -16.9% |
CLLS | Sell | CELLECTIS S Asponsored ads | $1,431,000 | -12.9% | 50,600 | -2.9% | 0.12% | -25.2% |
OXFD | New | OXFORD IMMUNOTEC GLOBAL PLC | $1,426,000 | – | 110,661 | +100.0% | 0.12% | – |
ITCI | Sell | INTRA CELLULAR THERAPIES INC | $1,412,000 | -26.3% | 79,900 | -12.2% | 0.12% | -36.8% |
DVAX | Sell | DYNAVAX TECHNOLOGIES CORP | $1,400,000 | -25.4% | 91,800 | -2.9% | 0.12% | -36.0% |
ARNA | New | ARENA PHARMACEUTICALS INC | $1,370,000 | – | 31,417 | +100.0% | 0.12% | – |
ALKS | Sell | ALKERMES PLC | $1,344,000 | -54.4% | 32,650 | -35.9% | 0.12% | -60.6% |
STIM | New | NEURONETICS INC | $1,320,000 | – | 50,000 | +100.0% | 0.11% | – |
AET | Sell | AETNA INC NEW | $1,303,000 | -14.3% | 7,100 | -21.1% | 0.11% | -26.5% |
SYNH | New | SYNEOS HEALTH INCcl a | $1,250,000 | – | 26,656 | +100.0% | 0.11% | – |
MRTX | New | MIRATI THERAPEUTICS INC | $1,257,000 | – | 25,500 | +100.0% | 0.11% | – |
AMRX | New | AMNEAL PHARMACEUTICALS INC | $1,231,000 | – | 75,000 | +100.0% | 0.10% | – |
CSLT | New | CASTLIGHT HEALTH INCcl b | $1,221,000 | – | 287,340 | +100.0% | 0.10% | – |
FMI | New | FOUNDATION MEDICINE INC | $1,142,000 | – | 8,357 | +100.0% | 0.10% | – |
TSRO | Sell | TESARO INC | $1,123,000 | -86.4% | 25,250 | -82.6% | 0.10% | -88.3% |
INGN | New | INOGEN INC | $1,120,000 | – | 6,011 | +100.0% | 0.10% | – |
COTV | Buy | COTIVITI HLDGS INC | $1,093,000 | +46.1% | 24,774 | +14.1% | 0.09% | +25.7% |
PFE | PFIZER INC | $1,059,000 | +2.2% | 29,200 | 0.0% | 0.09% | -12.6% | |
GWPH | Buy | GW PHARMACEUTICALS PLCads | $1,002,000 | +82.5% | 7,179 | +47.3% | 0.08% | +57.4% |
ENDP | Buy | ENDO INTL PLC | $934,000 | +153.1% | 99,092 | +59.3% | 0.08% | +116.2% |
CAH | Sell | CARDINAL HEALTH INC | $879,000 | -29.9% | 18,000 | -10.0% | 0.08% | -39.5% |
VEEV | New | VEEVA SYS INC | $791,000 | – | 10,296 | +100.0% | 0.07% | – |
CLVS | Sell | CLOVIS ONCOLOGY INC | $784,000 | -16.3% | 17,250 | -2.8% | 0.07% | -28.0% |
MRK | MERCK & CO INC | $759,000 | +11.5% | 12,500 | 0.0% | 0.06% | -3.0% | |
QURE | New | UNIQURE NV | $764,000 | – | 20,200 | +100.0% | 0.06% | – |
VAR | Sell | VARIAN MED SYS INC | $716,000 | -16.6% | 6,300 | -10.0% | 0.06% | -28.2% |
ADAP | New | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $711,000 | – | 59,935 | +100.0% | 0.06% | – |
BLCM | New | BELLICUM PHARMACEUTICALS INC | $664,000 | – | 90,020 | +100.0% | 0.06% | – |
HCSG | Sell | HEALTHCARE SVCS GRP INC | $648,000 | -60.8% | 15,000 | -60.5% | 0.06% | -66.5% |
MDCO | Sell | MEDICINES CO | $626,000 | +7.9% | 17,050 | -3.1% | 0.05% | -7.0% |
CVS | Sell | CVS HEALTH CORP | $515,000 | -5.9% | 8,000 | -9.1% | 0.04% | -18.5% |
MTLS | New | MATERIALISE NVsponsored ads | $510,000 | – | 39,329 | +100.0% | 0.04% | – |
NTLA | New | INTELLIA THERAPEUTICS INC | $458,000 | – | 16,734 | +100.0% | 0.04% | – |
MDSO | New | MEDIDATA SOLUTIONS INC | $375,000 | – | 4,649 | +100.0% | 0.03% | – |
AACH | Sell | AAC HLDGS INC | $365,000 | -27.3% | 39,000 | -10.8% | 0.03% | -38.0% |
VYGR | New | VOYAGER THERAPEUTICS INC | $331,000 | – | 16,922 | +100.0% | 0.03% | – |
EARS | New | AURIS MED HLDG AG | $151,000 | – | 193,125 | +100.0% | 0.01% | – |
EARS | Exit | AURIS MED HLDG AG | $0 | – | -216,963 | -100.0% | -0.03% | – |
MYGN | Exit | MYRIAD GENETICS INC | $0 | – | -11,800 | -100.0% | -0.04% | – |
SGRY | Exit | SURGERY PARTNERS INC | $0 | – | -31,000 | -100.0% | -0.05% | – |
ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -34,550 | -100.0% | -0.08% | – |
GKOS | Exit | GLAUKOS CORP | $0 | – | -30,000 | -100.0% | -0.09% | – |
EXEL | Exit | EXELIXIS INC | $0 | – | -49,800 | -100.0% | -0.11% | – |
PRTA | Exit | PROTHENA CORP PLC | $0 | – | -30,850 | -100.0% | -0.11% | – |
RDUS | Exit | RADIUS HEALTH INC | $0 | – | -33,300 | -100.0% | -0.12% | – |
IPXL | Exit | IMPAX LABORATORIES INC | $0 | – | -75,000 | -100.0% | -0.14% | – |
HALO | Exit | HALOZYME THERAPEUTICS INC | $0 | – | -75,800 | -100.0% | -0.15% | – |
NUVA | Exit | NUVASIVE INC | $0 | – | -32,312 | -100.0% | -0.17% | – |
PRGO | Exit | PERRIGO CO PLC | $0 | – | -33,000 | -100.0% | -0.27% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Bellevue Asset Management AG #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-07
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
IONIS PHARMACEUTICALS INC | 31 | Q3 2023 | 9.3% |
Vertex Pharmaceuticals Incorporated | 31 | Q3 2023 | 5.9% |
NEUROCRINE BIOSCIENCES INC | 31 | Q3 2023 | 5.7% |
Incyte Corporation | 31 | Q3 2023 | 5.4% |
INTUITIVE SURGICAL INC | 31 | Q3 2023 | 4.7% |
ABBOTT LABS | 31 | Q3 2023 | 4.6% |
ELEVANCE HEALTH INC | 31 | Q3 2023 | 4.3% |
UnitedHealth Group Incorporated | 31 | Q3 2023 | 3.6% |
ALNYLAM PHARMACEUTICALS INC | 31 | Q3 2023 | 3.7% |
Boston Scientific Corporation | 31 | Q3 2023 | 2.5% |
View Bellevue Group AG's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
SC 13G | 2023-02-14 |
SC 13G | 2023-02-14 |
13F-HR | 2022-11-14 |
View Bellevue Group AG's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.